FindTrial
Sign In

The effectiveness of Siddha and Allopathic treatment as reported by clinicians and patients

Clinical and patient-reported outcomes in patients receiving Siddha standard of care and allopathic standard of care for psoriasis: A prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/01/022884
Enrollment
192
Registered
2020-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Sponsors

Melaka Manipal Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with PASI score >10 2.Patient with Psoriasis Vulgaris (plaque psoriasis) and palmoplantar type of psoriasis 3.Patients with no systemic therapy for the past four weeks or topical therapy for the past two weeks

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women 2.Coexisting eczema or lichen planus 3.Patients on any systemic drugs known to exacerbate psoriasis 4.Patients who are on any other treatment for psoriasis

Design outcomes

Primary

MeasureTime frame
Number of patients reaching PASI 75 (75% improvement in the PASI score)Timepoint: 0,1,2,3,4 months—

Secondary

MeasureTime frame
Number of relapses in each patient Number of patients with different grades of remission Time taken to achieve different grades of remission Duration of remission Assessment of adverse effects Improvement in the patient-reported outcomes scoreTimepoint: 12 months—

Countries

India

Contacts

Public ContactDr Vasudha Devi

Melaka Manipal Medical College (Manipal Campus)

vasudha.devi@manipal.edu8971494100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026